首页|期刊导航|中国食品药品监管|医疗器械临床试验不良事件报告的实践困境与对策研究

医疗器械临床试验不良事件报告的实践困境与对策研究OA

Adverse Event Reporting in Medical Device Clinical Trials:Challenges and Countermeasures

中文摘要英文摘要

医疗器械临床试验不良事件监测与报告对于评价试验医疗器械的安全性至关重要.本研究通过系统梳理国内外相关法规、文献,并结合作者在临床试验管理实践中的经验,探讨当前我国医疗器械临床试验不良事件报告中面临的挑战,包括将研究者作为相关性判断的唯一责任主体、对潜在不良事件的预判和考虑不充分、伦理审查在维护研究参与者权益方面作用有限、不良事件随访和远期权益保障缺乏政策支持、安全性事件相关的监督与培训机制尚待完善等.针对这些挑战,本文提出了一系列优化措施思考,旨在提高医疗器械临床试验的科学性和伦理规范性,确保研究参与者的用械安全.

The monitoring and reporting of adverse event(AE)in medical device clinical trials play a crucial role in evaluating the safety of investigational devices.This study systematically reviews relevant domestic and international regulations and literature,and draws on the authors'hands-on experience in clinical trial management to explore the key challenges currently affecting AE reporting in China.These challenges include:over-reliance on investigators as the sole authority for causality assessment;insufficient anticipation and consideration of potential AEs during trial design;the limited role of ethics committees in protecting the rights and interests of research participants;the lack of clear policy support for AE follow-up and long-term participant protection;and inadequacies in safety-related oversight and training mechanisms.In response,this study proposes a series of targeted optimization measures aimed at enhancing the scientific rigor and ethical standards of medical device clinical trials and ensuring the safety of medical device use by research participants.

杨千粟;白楠;李珍珍;曹江;周吉银

中国人民解放军总医院医疗保障中心||中国人民解放军总医院第一医学中心伦理办公室中国人民解放军总医院医疗保障中心||中国人民解放军总医院第一医学中心伦理办公室中国人民解放军总医院医疗保障中心中国人民解放军总医院医疗保障中心||中国人民解放军总医院第一医学中心伦理办公室陆军军医大学第二附属医院临床医学研究中心

医药卫生

医疗器械临床试验不良事件严重不良事件伦理审查

medical devicesclinical trialsadverse eventsserious adverse eventsethical review

《中国食品药品监管》 2026 (3)

52-59,8

10.3969/j.issn.1673-5390.2026.03.005

评论